Serum SAP and PPBP levels in patients with chronic hepatitis C before DAA treatment could be measured by ELISAs and were highly positively correlated with the EV SAP and PPBP levels measured by targeted proteomics (Fig 3A). This evidence concerns the gene APCS and chronic hepatitis C virus infection.